Details for Patent: 9,889,144

Which drugs does patent 9,889,144 protect, and when does it expire?

Patent 9,889,144 protects YONSA and is included in one NDA.

This patent has fifty-eight patent family members in twenty-six countries.

Summary for Patent: 9,889,144

Title:	Abiraterone acetate formulation and methods of use
Abstract:	Pharmaceutical compositions, including unit dosage forms, comprising abiraterone acetate and methods for producing and using such compositions are described.
Inventor(s):	Murphy; Maura (Philadelphia, PA), Nemeth; Paul (Philadelphia, PA), Bosch; H. William (Philadelphia, PA), Callahan; Matthew (Philadelphia, PA), Bhamidipati; Satya (Philadelphia, PA), Coleman; Jason (Philadelphia, PA), Hill; Christopher (Philadelphia, PA), Norret; Marck (Darlington, AU)
Assignee:	iCeutica Inc. (Philadelphia, PA)
Application Number:	15/645,895
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,889,144
Patent Claim Types: see list of patent claims	Formulation; Compound; Dosage form;

Drugs Protected by US Patent 9,889,144

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Sun Pharm	YONSA	abiraterone acetate	TABLET;ORAL	210308-001	May 22, 2018		RX	Yes	Yes			Y

International Family Members for US Patent 9,889,144

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	095480
Australia	2014232508
Australia	2015317466